Top 50 Medical VC Funds & Investors in Middle East (August 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
OurCrowd
VC Fund
|
12 | Israel, United States, New Zealand | Series B, Series A, Seed | Software, Artificial Intelligence, Health Care | $593k–$65M |
|
Pontifax
VC Fund
|
10 | United States, Israel, France | Series A, Series B, Series C | Biotechnology, Health Care, Pharmaceutical | $6.3M–$130M |
|
Trendlines Group
VC Fund
|
8 | Israel, Singapore, United Kingdom | Seed, Series A | Health Care, Biotechnology, Medical Device | $650k–$15M |
|
Israel Innovation Authority
VC Fund
|
8 | Israel, United States, Mali | Grant, Seed, Pre-Seed | Health Care, Artificial Intelligence, Biotechnology | $130k–$5M |
|
Alesta Yatırım
VC Fund
|
6 | Turkey, United States, Estonia | Seed, Pre-Seed, Convertible Note | Software, Artificial Intelligence, Information Technology | $17k–$4.6M |
|
Alumni Ventures
VC Fund
|
6 | United States, United Kingdom, Canada | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $1.5M–$79M |
|
Diffusion Capital Partners
VC Fund
|
5 | Turkey, United States, United Kingdom | Seed, Series A | Software, Information Technology, SaaS | $350k–$2.7M |
|
HBL Hadasit Bio Holdings
VC Fund
|
5 | Israel | Seed, Series A | Biotechnology, Medical, Health Care | |
|
HIMAngel
VC Fund
|
5 | Egypt, Saudi Arabia, United States | Seed, Pre-Seed, Convertible Note | Food and Beverage, E-Commerce, Manufacturing | $100k–$350k |
|
aMoon Fund
VC Fund
|
4 | United States, Israel, France | Series B, Series A, Series C | Health Care, Biotechnology, Medical | $5.7M–$93M |
|
Agriline
VC Fund
|
4 | Israel | Seed, Series A, Venture - Series Unknown | Health Care, Medical, Medical Device | $1.3M–$17M |
|
Triventures
VC Fund
|
4 | United States, Israel, Ireland | Series A, Series B | Health Care, Medical Device, Medical | $6M–$28M |
|
F6 Ventures
VC Fund
|
4 | Egypt, United Arab Emirates, Saudi Arabia | Seed, Pre-Seed | Software, E-Commerce, Information Technology | $15k–$1.3M |
|
Vertex Ventures Israel
VC Fund
|
4 | Israel, United States, Canada | Series A, Series B, Series C | Software, Information Technology, Artificial Intelligence | $3.5M–$100M |
|
Btomorrow Ventures
VC Fund
|
4 | United States, United Kingdom, India | Series A, Seed, Series B | Health Care, Wellness, Food and Beverage | |
|
S2G Investments
VC Fund
|
4 | United States, Canada, Israel | Series A, Series B, Series C | Food and Beverage, Agriculture, Biotechnology | $3.9M–$100M |
|
Phoenician VC
VC Fund
|
3 | Lebanon, United Arab Emirates, Egypt | Seed, Series A, Pre-Seed | FinTech, Financial Services, Software | $50k–$8.4M |
|
Neo Ventures
VC Fund
|
3 | United States, United Kingdom, Israel | Seed, Series A | Software, Artificial Intelligence, SaaS | $500k–$24M |
|
CE Ventures (CEIIF)
VC Fund
|
3 | Israel, United States, India | Series B, Series A, Series C | Software, Analytics, Big Data | $4M–$40M |
|
MTIP AG
VC Fund
|
3 | United States, United Kingdom, Spain | Series A, Series B, Series C | Health Care, Medical, Artificial Intelligence | $1.5M–$80M |
|
AUC Angels
VC Fund
|
3 | Egypt, United Kingdom, United States | Seed, Pre-Seed, Angel | E-Commerce, Software, Retail | $40k–$1.2M |
|
Entrée Capital
VC Fund
|
3 | United States, Israel, United Kingdom | Seed, Series A, Series B | Software, FinTech, Financial Services | $1.5M–$60M |
|
Docor International Management
VC Fund
|
3 | Israel, United States | Series C, Series A | Health Care, Biotechnology, 3D Technology | $13M–$22M |
|
Qatar Development Bank
VC Fund
|
3 | Qatar, Turkey, India | Seed, Pre-Seed, Series A | Financial Services, FinTech, Information Technology | $52k–$12M |
|
ALIVE Israel HealthTech Fund
VC Fund
|
3 | Israel, United States | Series A, Series C, Series B | Health Care, Medical, Medical Device | $4.4M–$55M |
|
Ziegler Meditech Equity Partners
VC Fund
|
3 | United States, Israel | Series C, Series E, Series F | Health Care, Biotechnology, Mobile | |
|
Technion - Israel Institute of Technology
VC Fund
|
3 | Israel, United States | Seed, Series B, Venture - Series Unknown | Medical, Health Care, Therapeutics | $2.2M–$20M |
|
Acibadem University
VC Fund
|
3 | Turkey | Seed | Medical, Health Care, Medical Device | |
|
Falak Startups
VC Fund
|
3 | Egypt, United Arab Emirates, Canada | Pre-Seed, Seed, Venture - Series Unknown | E-Commerce, Health Care, Mobile Apps | $6k–$2.4M |
|
Connecticut Innovations
VC Fund
|
3 | United States, Israel, Canada | Seed, Series A | Health Care, Biotechnology, Software | $300k–$25M |
|
Terra Venture Partners
VC Fund
|
3 | Israel, United States | Seed, Series A, Series B | Software, Machine Learning, Artificial Intelligence | $1M–$30M |
|
Robin Hood Ventures
VC Fund
|
3 | United States, Canada, Israel | Seed, Series A | Software, Health Care, Biotechnology | $100k–$11M |
|
XTX Ventures
VC Fund
|
3 | United Kingdom, United States, Israel | Series A, Seed | Artificial Intelligence, Software, Machine Learning | $2M–$60M |
|
Tal Ventures
VC Fund
|
3 | Israel, United States, Cyprus | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, SaaS | $2.1M–$25M |
|
Insight Partners
VC Fund
|
3 | United States, Israel, Germany | Series B, Series A, Series C | Software, Information Technology, SaaS | $12M–$150M |
|
A15
VC Fund
|
3 | Egypt, United States, United Kingdom | Seed, Pre-Seed | E-Commerce, FinTech, Software | $50k–$8M |
|
Good Company
VC Fund
|
3 | Israel, United States | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, Recruiting | $400k–$22M |
|
OTV
VC Fund
|
2 | United States, Israel, Ghana | Series A, Series B, Seed | Health Care, Medical, Artificial Intelligence | |
|
ZORA Ventures
VC Fund
|
2 | Israel, United States, United Kingdom | Seed, Series A, Convertible Note | Biotechnology, Health Care, Internet | $1M–$8.1M |
|
Accelmed
VC Fund
|
2 | Israel, United States | Series D, Series A | Health Care, Medical Device, Medical | $695k–$96M |
|
Binder & Partners Ventures
VC Fund
|
2 | Israel, France, United States | Seed, Pre-Seed, Series A | Software, Information Technology, Health Care | |
|
Yozma Group
VC Fund
|
2 | Israel, United States, Australia | Series B, Seed | Health Care, Medical, Software | $2.5M–$59M |
|
DAI
VC Fund
|
2 | United States, Egypt | Seed | Health Care, Medical, Software | |
|
Flerie Invest
VC Fund
|
2 | Sweden, Israel, Iceland | Series A, Series B | Biotechnology, Health Care, Medical | |
|
Elron Ventures
VC Fund
|
2 | Israel, United States, China | Seed, Series A | Information Technology, Software, Health Care | |
|
HealthpointCapital
VC Fund
|
2 | Israel, United States | Series B, Series C | Medical, Biotechnology, Manufacturing | $5M–$15M |
|
Smith & Nephew
VC Fund
|
2 | United States, Israel, United Kingdom | Series B, Series C | Medical Device, Medical, Health Care | $2.7M–$30M |
|
fresh.fund
VC Fund
|
2 | Israel, United States, Norway | Seed, Pre-Seed, Series A | Health Care, Artificial Intelligence, Software | $300k–$21M |
|
Mangrove Capital Partners
VC Fund
|
2 | United States, United Kingdom, Israel | Series A, Seed, Series B | Software, E-Commerce, Information Technology | |
|
Angular Ventures
VC Fund
|
2 | Israel, United States, United Kingdom | Seed, Pre-Seed, Series A | Software, SaaS, Artificial Intelligence | $1.2M–$45M |
| Access all 50 VC funds in Middle East Medical startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Invest in exclusive and pre-vetted startups, late-stage companies, and top tier funds - private market access made simple, transparent, and institutional-grade.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Series B, Series A, Seed
- Geography: Israel, United States, New Zealand
Investor stats
- Total investments: 309
- Round size: Seed $593k–$10M; Series A $5.3M–$34M; Series B $8M–$65M
- Lead/follow: 16% lead, 84% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- N.Light — N.Light is a Metaverse 3D design software that allows individuals to effortlessly turn their ideas into reality.
- Hemispheric — Hemispheric develops fundamental AI technologies aimed at deciphering brain activity for innovative applications.
- MUV Interactive — MUV Interactive designs and develops innovative technology for active human sensing, providing a natural and fluent interactive experience with any type of digital application, from displayed content, and smart home appliances to IOT (Internet of Things) devices, drones and AR/VR applications. The company’s flagship product, Bird, is anintuitive device that is worn on the index finger, which transforms any space into a 3D Interactive Environment. Bird is the first device to integrate the entire spectrum of input and control methods – including touch, remote touch, gesture control and mouse functionality. This gives users the flexibility to interact with each type of digital content in the most intuitive way, whether up close or from a distance of up to 100 feet away.
Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series A, Series B, Series C
- Geography: United States, Israel, France
Investor stats
- Total investments: 117
- Round size: Series A $6.3M–$110M; Series B $20M–$130M; Series C $12M–$101M
- Lead/follow: 24% lead, 76% follow
- Last fund: May invest from a new fund soon — raised $14M in 2020
Portfolio highlights
- ArQule — ArQule, Inc. is a clinical-stage biotechnology company engaged in the research and development of cancer therapeutics. The Company employs technologies, such as its ArQule Kinase Inhibitor Platform (AKIP) to design and develop drugs. The Company's product is ARQ 197, an orally administered inhibitor of the c-Met receptor tyrosine kinase. ARQ197 is being evaluated as monotherapy and in combination therapy in a Phase II clinical development program that includes trials in Microphthalmia Transcription Factor (MiT) associated tumors, non-small cell lung cancer (NSCLC), pancreatic adenocarcinoma and hepatocellular carcinoma (HCC). The Company has licensed commercial rights to ARQ 197 for human cancer indications to Daiichi Sankyo Co., Ltd. (Daiichi Sankyo) in the United States, Europe, South America and the rest of the world, excluding Japan and certain other Asian countries, where it has licensed commercial rights to Kyowa Hakko Kirin Co., Ltd. (Kyowa Hakko Kirin).
- Otic Pharma — Otic Pharma is a clinical-stage pharmaceutical company focusing on the development and commercialization of products for disorders of the ear, nose, and throat (ENT). The company has two platform technologies, each of which has the potential to be developed for multiple ENT indications. The company is currently developing anasally-administered, combination drug product (OP-02) intended to address the underlying cause of otitis media and Eustachian tube dysfunction (OM/ETD), a condition that affects more than 700 million people around the world every year. Otitis media is one of the most common disease seen in pediatric practice and the most frequent reason children consume antibiotics or undergo surgery. The company also has a foam-based drug delivery technology platform (OP-01) that can be used to deliver drugs into the ear, nose, and sinus cavities. The company is currently developing OP-01 as an improved treatment option for acute otitis externa (“swimmers ear”). For more information on the company, please visit www.oticpharma.com
- Applied Immune Technologies — Applied Immune Technologies Ltd. engages in development of therapeutic molecules for cancer, viral, and autoimmune diseases. The company develops T-Cell Receptor-Like (TCRL) antibodies that are targeted to intracellular-derived peptides for various therapeutic and diagnostic applications. Its TCRL antibodies also have diagnostic applications inpathology; and vaccine design, validation, and monitoring, as well as in the analysis of antigen presentation in disease. The company was formerly known as BioMimic Pharma. The company was founded in 2006 and is based in Haifa, Israel.
Trendlines Group invents, discovers, invests in, and incubates innovation-based medical and agrifood technologies. Trendlines invests principally through medical and agrifood incubators in Israel and in Singapore, its in-house innovation center, Trendlines Labs, and its Funds - the Trendlines Agrifood Fund and the Bayer Trendlines Ag InnovationFund.The company was founded in 1993 and is headquartered in Misgav, Israel.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Seed, Series A
- Geography: Israel, Singapore, United Kingdom
Investor stats
- Total investments: 70
- Round size: Seed $650k–$4.1M; Series A $2.3M–$15M
- Lead/follow: 21% lead, 79% follow
- Last fund: May invest from a new fund soon — raised $40M in 2019
Portfolio highlights
- IBI-Ag — We develop a wide array of selective bio-insecticides to help farmers grow more at lower cost with no harm to farm workers, consumers and the environment.
- Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
- Arcuro Medical — Arcuro develops a new repair system for meniscus tears of the knee. Arcuro’s proprietary SuperBall repair system consists of a knotless, all-suture anchor and innovative delivery system. The company was founded in 2013.
The Israel Innovation Agency, the Innovation Authority, was established in 1965 as the Office of the Chief Scientist of the Ministry of Industry and Trade and was designed as a body that supports R & D conducted in the framework of government research institutes. Industrial development in order to increase industrial exports of high-techproducts. The Chief Scientist focused on reducing the risk by participating in financing the project, which the private companies chose and led.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Biotechnology
- Stage:Grant, Seed, Pre-Seed
- Geography: Israel, United States, Mali
Investor stats
- Total investments: 200
- Round size: Seed $500k–$5M; Grant $130k–$3.5M; Pre-Seed $150k–$2.1M
- Lead/follow: 48% lead, 52% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Brevel — Brevel developed a disruptive cultivation technology for sustainable, low cost and high quality production of microalgae for various yet untapped markets. The technology is based on high-tech indoor, sterile and fully automated systems which are illuminated from within at high intensity. The technology enables the surprising results of more than90% cost reduction and up to 200 higher yields compared to current alternatives. Brevel is using the advantageous production capabilities to enter multiple markets where microalgae derived products are needed.
- NanoGhosts — NanoGhosts’ technology is based on its founder’s research, that the Technion's commercial unit has patented in the U.S. and Europe.
- GeoRank Studio — Get your business ranked on Google, cited by ChatGPT & Perplexity, and protected from reputation damage. Specialist SEO and GEO agency. Free consultation.
Ales Venture Capital Investment Trust Inc. 100% Escort Technology Investment Co., Ltd. was established in late 2012 as a subsidiary of an investment company subject to the Capital Markets Board legislation.Their target audience was primarily started to produce products or services are targeted at companies with existing customers and growth.However, the product or service to switch to the sales and marketing process, although in need of ready finance companies also take interest in Their initiative.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Pre-Seed, Convertible Note
- Geography: Turkey, United States, Estonia
Investor stats
- Total investments: 122
- Round size: Seed $17k–$645k; Pre-Seed $26k–$150k; Convertible Note $30k–$4.6M
- Lead/follow: 21% lead, 79% follow
- Last fund: May invest from a new fund soon — raised $5M in 2012
Portfolio highlights
- GlaucoT — GlaucoT develops contact-free intraocular pressure monitoring and neuroprotective treatment technology for glaucoma disease.
- Kozmonot — Kozmonot is a mobile competition application with real money prizes focused on knowledge, research and intelligence.
- ConverJinn — AI-powered product categorization and conversion optimization for online stores. Boost conversions and make every product page count.
Access curated startup investment opportunities and diversified venture capital exposure designed for accredited investors.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 2214
- Round size: Seed $1.5M–$10M; Series A $5.5M–$35M; Series B $12M–$79M
- Lead/follow: 5% lead, 95% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- WINN.AI — WINN.AI helps revenue teams run better sales calls and win more deals by automating admin work and guiding reps live, during the call.
- Car Body Lab — The easy way, online.
- Perennial — Cloud Agronomics is the platform for soil carbon management.
Diffusion Capital Partners (DCP) is Turkey's leading Venture Capital fund manager with a focus on deep-tech opportunities.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Seed, Series A
- Geography: Turkey, United States, United Kingdom
Investor stats
- Total investments: 60
- Round size: Seed $350k–$2.7M; Series A $985k–$2.5M
- Lead/follow: 57% lead, 43% follow
- Last fund: May invest from a new fund soon — raised $32M in 2020
Portfolio highlights
- FU — The FU carries out mortgage business, which guarantees the loans of banks and financial institutions, loans of non-financial institutions.
- TAZI — TAZI's Automated Machine Learning is understandable continuous machine learning from data and humans, enables business domain experts to use machine learning to ...
- V-Count — V-Count is a leading global provider of AI-powered visitor analytics and people-counting solutions for physical locations.
Hadasit Bio-Holdings Ltd. ("HBL") was founded and floated on the Tel Aviv Stock Exchange (TASE : HDST ) and recently on the OTC (OTCBB : HADSY ) in order to allow public participation in the highly promising field of biotechnology.It serves as a precedent in biotech financing - for the first time, public investment is allowed toparticipate in a holding entity including companies based on IP generated by Israel’s foremost medical research center – Hadassah University Hospital ("HU").In addition to the public holdings (54%) – including major Israeli institutional investors, HBL is held by Hadasit (www.hadasit.co.il) (36%) and Consensus Business Group (http://www.consensusbusiness.com) (10%). The traded stock, as a unique investment vehicle, provides investment exposure to a select cluster of 6 biotech companies - all based on inventions developed and owned by HU.HBL is a publicly traded subsidiary of Hadasit Ltd. – the technology transfer company of the Hadassah University Hospital in Jerusalem, Israel. Hadasit was established for the purpose of promoting and commercializing the intellectual property (IP) and R&D capabilities generated by Hadassah, aimed at finding solutions to problems faced by modern medicine.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Seed, Series A
- Geography: Israel
Investor stats
- Total investments: 11
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- ProtAb — ProtAb develops therapeutic agents that modulate cytokine regulation, tipping the balance toward anti-inflammatory signaling pathways in the treatment of autoimmune and inflammatory diseases. Its first product, Prozumab, is a monoclonal antibody with a novel mechanism of action. It is currently in late-stage preclinical development for thetreatment of inflammatory bowel disease or IBD, ulcerative colitis or UC, and rheumatoid arthritis or RA. It operates as a subsidiary of Hadasit Bio-Holdings. HBL is a publicly traded subsidiary of Hadasit, the technology transfer company of the Hadassah University Hospital in Jerusalem in Israel.
- KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
- Enlivex Therapeutics — Enlivex is a clinical-stage macrophage reprogramming immunotherapy company that targets diseased macrophages in patients with sepsis. The company develops an autologous and allogeneic drug pipeline for the treatment of autoimmune and inflammatory conditions such as Graft versus Host Disease (GvHD), solid organ transplant rejection, Crohn'sDisease, and other autoimmune and inflammatory disorders.The company's revolutionary approach is to induce immune tolerance by injecting apoptotic cells and facilitating their interaction with dendritic cells activates the body's innate, physiologic mechanism for down-regulating inflammation and autoimmunity.Enlivex is an Israeli-based cell immunotherapy company established in October 2005 by Professor Dror Mevorach, a world-renowned expert on clearance of dying (apoptotic) cells.
HIMAngel is a venture capital and private equity firm that supports early-stage startups to grow. It fills the funds' gap as there is an increasing focus on growth-stage VC funds, but little attention and even less money made available for early-stage investments. HIMAngel was founded in 2017 and headquartered in Cairo, Al Qahirah.
Show more...Investment focus
- Industry: Food and Beverage, E-Commerce, Manufacturing
- Stage:Seed, Pre-Seed, Convertible Note
- Geography: Egypt, Saudi Arabia, United States
Investor stats
- Total investments: 26
- Round size: Seed $100k–$350k
- Lead/follow: 42% lead, 58% follow
Portfolio highlights
- Rology — AI-assisted On-demand Teleradiology Platform
- GBarena — GBarena is an online esports platform that serves the ecosystem stakeholders by the combination of a strong network of different esports communities, and a highly analytical tool to provide authentic value for all stakeholders (Publishers, Gamers, Tournament Organizers, Sponsors, Teams, and Media Partners).
- FreshSource — FreshSource is revolutionizing the agriculture value chain through a tech-based B2B platform that is disrupting the distribution model of horticulture produce.
aMoon is a leading healthtech & life sciences venture fund founded by Marius Nacht and Dr. Yair Schindel. Their team is passionate about building successful businesses and helping biopharma, digital health and medical technology companies realize their potential. They partner with management teams who use technology and cutting-edge science toaccelerate cures for the world’s most life-threatening conditions and those providing solutions for global healthcare’s biggest cost drivers.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, Israel, France
Investor stats
- Total investments: 79
- Round size: Series A $5.7M–$82M; Series B $22M–$93M; Series C $30M–$82M
- Lead/follow: 49% lead, 51% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Adcytherix — Adcytherix is a biopharmaceutical company focused on the development of novel antibody drug conjugates (ADC) to treat high unmet need diseases such as cancer.
- Lin Health — Online chronic pain recovery program designed to get you back to the life you want to live. One-on-one coaching. Real pain reduction results.
- Connie Health — At Connie Health, our Medicare advisors help older Americans find the right Medicare plan - all at no cost to you.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Agriline is the investment vehicle owned by a trust of which Trendlines' controlling shareholder Vincent Tchenguiz.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Israel
Investor stats
- Total investments: 15
- Round size: Seed $1.3M–$7.5M; Series A $5M–$17M; Venture - Series Unknown $2.2M–$16M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
- Vessi Medical — Vessi Medical is developing an innovative, IP protected cryo spray for hollow & humid organs, a new approach in the treatment of Non Muscle Invasive Bladder Cancer (NMIBC).
- SetBone Medical — SetBone Medical develops a new bone cement for the treatment of VCF and primarily caused by osteoporosis.
Triventures is a global, early stage fund that invests in exceptional entrepreneurs. We partner with disruptive ventures with innovative breakthroughs in healthcare and beyond. Our vision is to create a better, healthier future through data driven solutions and cross industry convergence.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series A, Series B
- Geography: United States, Israel, Ireland
Investor stats
- Total investments: 60
- Round size: Series A $6M–$24M; Series B $6M–$28M
- Lead/follow: 30% lead, 70% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Grin — Grin is a comprehensive digital orthodontic platform providing teeth straightening for all types of patients with a real local orthodontist. The platform also connects patients with a real orthodontist from the convenience of their smart device. They deliver responsible care from orthodontic specialists in an easily accessible and cost-effectiveway, Grin provides patients quality care that results in an exceptional smile together with all of the modernized convenience that they expect.Grin technology, aligned with a network of local trusted orthodontists, ensures that every patient gets the right care. The platform Grin App and Grin Scope is a patent-pending technology that offers remote monitoring for a variety of orthodontic needs. The Grin experience includes high-quality self-scans with the latest teeth straightening solutions. Practitioners and patients can now use these telemedicine tools to achieve a new, more convenient treatment journey.It was founded by Dr. Adam Schulhof, Pamela Oren-Artzi, and Alon Lipnik in 2019 and is based in New York and Austin.
- Cala Health — Cala Health is a bioelectronic medicine company transforming the standard of care for chronic disease. The company's wearable neuromodulation therapies merge innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation. The first indication for Cala Health's wearable therapy is an essential tremor, adisease experienced by more than seven million people and characterized by severe hand tremors. New therapies are under development in neurology, cardiology, and psychiatry. The company is headquartered in the San Francisco Bay Area and backed by leading investors in both healthcare and technology.
- TailorMed — Moving Mountains for Patients
F6 Ventures is a leading seed stage venture capital firm operating across emerging markets. We back exceptional founders from idea-stage all the way to Series A, combining early capital with strategic support and a commitment to long-term partnership. With deep ties across the Middle East, Africa, and beyond, we empower innovative startups to scalewith purpose and impact. We manage over $90M in AUM across more than 300 investments in seven countries. By investing early in Pre-Seed to Pre-Series A rounds, we help founders cover initial costs, develop their product, and take it to market. This early capital acts as a launchpad, enabling startups to hit key milestones like securing first customers, attracting follow-on funding, and making significant strides forward.
Show more...Investment focus
- Industry: Software, E-Commerce, Information Technology
- Stage:Seed, Pre-Seed
- Geography: Egypt, United Arab Emirates, Saudi Arabia
Investor stats
- Total investments: 307
- Round size: Seed $15k–$1.3M; Pre-Seed $32k–$650k
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- lululittle — lululittle combines storytelling with cultural themes to create empowering personalized books where your children are the heroes. We use the power of personalized storytelling to create inspiring and engaging reading experiences, placing your kids at the center of these stories. Our stories are inspired by relevant cultural themes that aim toempower kids in their diverse cultural environments. Our first story is inspired by the Arab world's rich culture and is suited for kids age 0-10. lululittle's easy to use online platform lets you personalize, preview, and order their book in just a few minutes.
- Makan Home — SHEN168 adalah situs toto togel online yang terpercaya, menawarkan pengalaman bermain yang aman dan menyenangkan bagi para penggemar togel online.
- Ouda W Dar — Ouda W Dar is an online platform that helps hosts and guests book unique short-term accommodations.
We partner early with global-minded entrepreneurs seeking to disrupt large markets
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series A, Series B, Series C
- Geography: Israel, United States, Canada
Investor stats
- Total investments: 184
- Round size: Series A $3.5M–$28M; Series B $4.7M–$35M; Series C $5.6M–$100M
- Lead/follow: 17% lead, 83% follow
- Last fund: May invest from a new fund soon — raised $70M in 2018
Portfolio highlights
- Rylo — Nagish captions your phone calls and empowers you to talk using text or voice. It's fast, private, and free.
- Aternity — Unlocking the full potential of your digital experiences has never been more accessible. Illuminate, accelerate and fully leverage the full breadth of possibilities with Riverbed.
- Quantum Art — Quantum Art develops scalable, multi-core quantum computers with advanced trapped ion qubits and multi-qubit gates, accelerating breakthroughs in AI, finance, and materials science.
Btomorrow Ventures (BTV) is the corporate venturing unit of BAT. BAT is building A Better Tomorrow by reducing the health impact of its business by transforming into a truly consumer-centric multi-category CPG company. We are dedicated to partnering with ambitious and passionate entrepreneurs to realise their vision by providing a platform toenhance innovation and accelerate growth.
Show more...Investment focus
- Industry: Health Care, Wellness, Food and Beverage
- Stage:Series A, Seed, Series B
- Geography: United States, United Kingdom, India
Investor stats
- Total investments: 44
- Lead/follow: no public data
Portfolio highlights
- Tru — Obsessively formulated by fusing flavor with function, each of our tasty innovations perform when you need it most. From the time you wake up until the second your head hits the pillow, we elevate every moment one sip at a time.
- Awake Chocolate — AWAKE Chocolate combines delicious milk chocolate.
- PHILTER Labs — Philter Labs presents an innovative smoke filter for E-Cig, Vape Pen, & CBD Pen. Filters smoke from entering shared space while you still enjoy the experience.
S2G Ventures is is a multi-stage venture fund investing in food and agriculture. We're harnessing the power of food innovation to create better outcomes for people and the planet.
Show more...Investment focus
- Industry: Food and Beverage, Agriculture, Biotechnology
- Stage:Series A, Series B, Series C
- Geography: United States, Canada, Israel
Investor stats
- Total investments: 215
- Round size: Series A $4M–$50M; Series B $3.9M–$100M; Series C $9.4M–$92M
- Lead/follow: 48% lead, 52% follow
Portfolio highlights
- Atomo Coffee — Atomo Coffee is a developer of molecular coffee. Atomo has reverse-engineered the coffee bean to create a smooth cup of coffee, made of naturally derived ingredients, and more sustainable than current commercial coffee.
- SWARM — SWARM is a Software-as-a-Service platform that uses a next generation cognitive computing system, structured around a multi-agent approach which can utilize a cur
- Kuehnle Agrosystems — Kuehnle AgroSystems curates a unique set of algae originating from pristine waters and ecosystems of Hawaii, as well as tropical botanical accessions representing plants prized by Polynesian voyagers.
Founded in 2015, Phoenician Funds is at the heart of thriving capitals of digital innovation and startup ecosystems in the Middle East and North Africa ...
Show more...Investment focus
- Industry: FinTech, Financial Services, Software
- Stage:Seed, Series A, Pre-Seed
- Geography: Lebanon, United Arab Emirates, Egypt
Investor stats
- Total investments: 24
- Round size: Seed $700k–$3M; Pre-Seed $50k–$1M; Series A $1.5M–$8.4M
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — raised $30M in 2015
Portfolio highlights
- Go Rise — Go Rise is a start-up building a financial services platform for migrants.
- Ostaz — Ostaz is an education technology (EdTech) company focused on delivering AI-powered personalized tutoring services across the Middle East, particularly in the UAE, Saudi Arabia, and Lebanon. The platform connects students with qualified tutors while using artificial intelligence to improve tutor-student matching and educational outcomes.
- TWIG — TWIG is a Bank Agnostic Automated Savings Platform in the MENA region. Our flagship app provides Automated Saving Plans to help users save better; a Smart Budgeting tool with tailored insights; and Smart, customizable and user-specific Goals.
Neo Ventures is a venture capital investment platform focused on deep tech, funds and high-growth startup portfolio.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Series A
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 18
- Round size: Seed $500k–$2.9M; Series A $2.3M–$24M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Bulbi — Bulbi is a child development platform designed to help parents discover online and face-to-face educational activities for their children.
- Convex — All gas, no breakages. Convex is the reactive backend platform that keeps up with you and your agents.
- Extend Robotics — Extend Human Capabilities Beyond Physical Presence
CE Ventures was established in 2015 to focus on investments in private technology companies located in Israel and the United States. It considers opportunities across a broad spectrum of industries, including technology, media, telecommunications and digital health and invests in a mixture of early and later-stage opportunities.
Show more...Investment focus
- Industry: Software, Analytics, Big Data
- Stage:Series B, Series A, Series C
- Geography: Israel, United States, India
Investor stats
- Total investments: 34
- Round size: Series A $4M–$7M; Series B $4M–$30M; Series C $10M–$40M
- Lead/follow: 35% lead, 65% follow
- Last fund: May invest from a new fund soon — last raise in 2016
Portfolio highlights
- DiA Imaging Analysis — DiA is the leading provider of FDA cleared and CE marked ultrasound AI solutions that make the use and analysis of ultrasound images smarter, faster and accessible to all. Our solutions address the main challenges ultrasound users face - manually capturing and visually analyzing ultrasound images.
- NirogStreet — NirogStreet is the best platform for Ayurveda doctors. Learn and Earn from top Ayurveda Experts and get authentic Ayurvedic medicines at the best deals.
- Centrical — Centrical helps businesses improve employee engagement, proficiency, and performance through gamification, microlearning, and performance management.
MTIP is a growth capital investor that specializes in scaling up healthtech companies in rapidly expanding global markets. Visit our website!
Show more...Investment focus
- Industry: Health Care, Medical, Artificial Intelligence
- Stage:Series A, Series B, Series C
- Geography: United States, United Kingdom, Spain
Investor stats
- Total investments: 28
- Round size: Series A $1.5M–$36M; Series B $10M–$30M; Series C $9.3M–$80M
- Lead/follow: 57% lead, 43% follow
- Last fund: Likely still investing — raised $250M in 2021
Portfolio highlights
- TrialBee — Trialbee is revolutionizing clinical trials with innovative global patient recruitment solutions. Streamline your recruitment process today.
- Verifarma — Verifarma offers comprehensive, robust & high-quality services to drugs, medical products, chemical precursors, agrochemicals.
- NitiNotes — Nitinotes has developed the EndoZipTM, a fully automated, operator independent gastroscopic suturing system, allowing gastroenterologists as well as surgeons to bring a durable solution to their patients. The procedure creates an effect of stomach volume restriction and motility impair - both are needed to help obese patients reducing weight.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!What is AUC Angels? AUC Angels is the first university-based angel investor network in the MENA region. Angel investors are individuals who are interested in investing in early-stage startups with growth potential which in turn supports the growth of a dynamic entrepreneurship ecosystem in Egypt.
Show more...Investment focus
- Industry: E-Commerce, Software, Retail
- Stage:Seed, Pre-Seed, Angel
- Geography: Egypt, United Kingdom, United States
Investor stats
- Total investments: 34
- Round size: Seed $100k–$1.2M; Angel $100k–$230k; Pre-Seed $40k–$200k
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Roboost — Tayar is an enterprise solution using Artificial intelligence and complex Algorithms to facilitate, optimize, and manage the delivery process to any BTC (mainly home delivery) business to increase the delivery speed and performance.
- InCurA — Why InCurA ProductsWe Innovate Medical Devices for Today, Tomorrow and What's Needed NextInCurA is developing a pipeline of products based on its unique
- UNLOCK — Companies looking to outsource certain department functions should look no further than Unlock EPN. A complete and diverse business directory of agencies and companies in Egypt. All are available with direct contact information for your convenience.
We are a team of former serial founders managing $1.5Bn across a number of funds, with offices in Tel Aviv, London, and New York. We back the next generation of category-defining companies with conviction of founders who have built companies themselves.We back founders with a partnership built on trust, fairness and real operating experience. Westand with founders through every challenge, and help them grow with clarity, resilience and purpose.
Show more...Investment focus
- Industry: Software, FinTech, Financial Services
- Stage:Seed, Series A, Series B
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 278
- Round size: Seed $1.5M–$15M; Series A $5M–$30M; Series B $14M–$60M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely still investing — raised $300M in 2022
Portfolio highlights
- Classiq Technologies — A software platform that helps users create scalable complex quantum computer algorithms, software, and circuits for any gate-based quantum computer
- Identiq — Identiq's network members fight fraud and improve user experience by validating new users and vouching for ones they already know without sharing any personal user data at all.
- IRP Systems — IRP Systems delivers high performance electric vehicle systems, EVVER e-powertrains and TrueDRIVE control software for fast integration.
Docor International B.V. is a fully-owned subsidiary of Crecor B.V. Both Docor and Crecor were formed as wholly-owned subsidiaries of the Van Leer Group Foundation to promote and participate in commercial activities in Israel.
Show more...Investment focus
- Industry: Health Care, Biotechnology, 3D Technology
- Stage:Series C, Series A
- Geography: Israel, United States
Investor stats
- Total investments: 14
- Round size: Series C $13M–$22M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Check-Cap — Check-Cap Ltd. is merging with MBody AI to create a leading publicly traded embodied AI company powering autonomous workforces.
- Ocon Healthcare — OCON Healthcare innovates, develops, manufactures, and commercializes cutting-edge women’s health products based on our patented IUB™ (Intra Uterine Ball) proprietary platform. The IUB™, made from a super-elastic alloy Nitinol, is an ideal carrier for multiple drugs to the uterus to treat a variety of conditions.In addition to our flagshipproduct, the IUB™ Ballerine®, OCON healthcare is developing an innovative pipeline of products utilizing the IUB™ frame for indications such as abnormal uterine bleeding (AUB), heavy menstrual bleeding (HMS), myomas/fibroids, and infertility.
- Raziel Health — Raziel Health’s mission is to bring world-class, disruptively less expensive healthcare to everyone, in the comfort of their home. Its unique, integrated system combines easy-to-use technologies that support positive patient experience, enable timely clinical intervention, and meet individual patient goals while using data analytics to supportwellness and disease management.
Qatar Development Bank they improve the economic development cycle by providing entrepreneurs and SMEs with a wide range of financial and advisory products under one roof.
Show more...Investment focus
- Industry: Financial Services, FinTech, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: Qatar, Turkey, India
Investor stats
- Total investments: 48
- Round size: Seed $370k–$2.5M; Pre-Seed $52k–$1.2M; Series A $3.6M–$12M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- Aumet — Aumet allows medical manufacturers and distributors increase their sales by sharing hospital inquiries, business news, search for products, and find potential clients.Manufacturers and distributors who work together connect and get verified so they share hospital inquiries, market business news between each other .Suppliers list their productsand connect with distributors who sell these products and select countries, where they are looking for distributors, in the meantime distributors, connects with their suppliers, search for new product and list their interests.
- Wellbees — Wellbees provides a digital platform that helps organizations support employee wellbeing and engagement through personalized experiences and wellbeing programs. The platform offers access to one-on-one sessions with specialists such as psychologists, dietitians, physical trainers, and therapists, as well as educational content, webinars, and guidedactivities. Employees can participate in clubs, events, and challenges, track their progress, and receive AI-based recommendations tailored to their individual needs. For employers, Wellbees includes analytics tools, employee surveys, and dashboards that provide aggregated insights into wellbeing, engagement, and platform usage. The platform integrates with workplace applications such as Microsoft Teams and Slack and is available through web and mobile applications.
- Multiverse Computing — World leaders in quantum computing for the financial industry. The first quantum & quantum-inspired toolbox for finance.
ALIVE Israel HealthTech Fund is a pioneer mid-to-late stage HealthTech fund leveraging an exclusive ecosystem.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Series A, Series C, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 15
- Round size: Series A $4.4M–$17M; Series B $22M–$30M; Series C $30M–$55M
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Navina — Navina uses medically-informed AI to replace disorganized patient data with an intuitive Patient Portrait - a logical grid that makes it possible for every primary care physician to assess even the most complex cases in minutes. Designed for and loved by physicians, Navina allows for high quality and empathic patient care, resulting in better treatment, reduced missed diagnoses and enhanced financial performance for providers and payers.
- Vessi Medical — Vessi Medical is developing an innovative, IP protected cryo spray for hollow & humid organs, a new approach in the treatment of Non Muscle Invasive Bladder Cancer (NMIBC).
- Magenta Medical — Founded in October, 2012, Magenta Medical Ltd. is a privately held company that is engaged in the development of novel device solutions for the treatment of acute and chronic heart failure.
Ziegler is a privately held investment bank, capital markets and proprietary investments firm.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Mobile
- Stage:Series C, Series E, Series F
- Geography: United States, Israel
Investor stats
- Total investments: 6
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Aposense — Aposense (formerly NST) is a clinical-stage molecular imaging and drug development company, with a pipeline of products based on its patented platform technology for targeting apoptosis (programmed cell death) in vivo. The company translating the science of Apoptosis (programmed cell death) into personalized patient care in multiple diseasecategories, including oncology, cardiology, and neurology. Targeting of this important biological process in-vivo opens opportunities for real-time clinical imaging of disease activity and targeted therapy.Aposense specializing in the development of novel drugs and utilizing membrane electrical forces for trans-membrane of macromolecule drugs, mainly siRNA. It also developed rationally-designed molecular nano-motors (MNMs), being novel small-molecule chemical entities and its translation into kinetic energy for movement within the hydrophobic membrane core.Aposense was founded in 1996 and is headquartered in Petah Tiqva, HaMerkaz, Israel.
- MAKO Surgical — MAKO Surgical is a medical device company, markets its advanced robotic arm solution, joint specific applications for the knee and hip, and orthopedic implants for orthopedic procedures in the United States and internationally. The company offers MAKOplasty, a restorative surgical solution that enables orthopedic surgeons to treat patient specificosteoarthritic disease. It also provides robotic arm interactive orthopedic system (RIO) consisting of a tactile robotic arm utilizing an integrated bone cutting instrument; and a patient specific visualization component, which offers pre-operative and intra-operative guidance to the orthopedic surgeon, enabling tissue sparing bone removal, and accurate implant insertion and alignment.In 2011, The company was named the No.1 on the Technology Fast 500 as the fastest growing technology company by Deloitte and received the CSSEC Award for loyal, customer-focused staff members presented by the Technology Services Industry Association and ACE Award (Achievement in Customer Excellence) from MarketTools and Fast Tech Award as one of the 25 fastest growing technology companies in South Florida by South Florida Business Journal.MAKO Surgical was founded in 2004 and is headquartered in Florida, USA.
- MobileAccess Networks — Corning Everon Network Solutions offer in-building cellular solutions to meet a broad array of design scenarios and mitigate RF propagation challenges.
“Technikum” - the original German name of the Technion - is a tale of the century. The second industrial revolution created the printing presses and communications infrastructure allowing Jews scattered across the globe to organize in face of rising anti-Semitism. As Jews were often barred from technical education, the establishment of a technicalschool was a first priority to rebuilding a Jewish homeland. The Technion was to become unique worldwide as a university that would precede, create, shape, and protect a modern state.The cornerstone laid on April 11, 1912, set in motion a century of progress responding to national and global needs. Technion would grow rapidly, becoming a global pioneer in fields such as biotechnology, stem cells, space, computer science, nanotechnology, and energy. Three Technion professors have won Nobel Prizes. As it celebrates its cornerstone centennial in 2012, Technion City is a thriving world center of research and teaching, with 12,850 students and 80 graduate programs trailblazing excellence in research and teaching for the benefit of humanity.
Show more...Investment focus
- Industry: Medical, Health Care, Therapeutics
- Stage:Seed, Series B, Venture - Series Unknown
- Geography: Israel, United States
Investor stats
- Total investments: 5
- Round size: Seed $2.2M–$20M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Mana.bio — Mana.bio is an AI based drug delivery startup, focusing on gene therapy including RNA and DNA-based therapeutics and vaccines
- ViAqua Therapeutics — ViAqua is developing the first orally administered treatment in aquaculture to stop diseases from developing and to prevent viral epidemics.
- Levron Medical — Levron Medical develops a novel autonomic integrated diagnostic and therapeutic device used to treat heart failure patients.
Acibadem University is the Largest Private Healthcare University in Turkey
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Stage:Seed
- Geography: Turkey
Investor stats
- Total investments: 3
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Hevi AI — Hevi AI provide innovative artificial intelligence-based solutions for medical imaging for a diverse spectrum of diseases varying from detection of critical pathologies to radiomics applications for oncology.
Falak Startups is a start-up accelerator designed to support and empower the next generation of Egyptian entrepreneurs and contribute to the development of the start-up ecosystem in Egypt.
Show more...Investment focus
- Industry: E-Commerce, Health Care, Mobile Apps
- Stage:Pre-Seed, Seed, Venture - Series Unknown
- Geography: Egypt, United Arab Emirates, Canada
Investor stats
- Total investments: 74
- Round size: Seed $31k–$2.4M; Pre-Seed $6k–$360k
- Lead/follow: 24% lead, 76% follow
Portfolio highlights
- InCurA — Why InCurA ProductsWe Innovate Medical Devices for Today, Tomorrow and What's Needed NextInCurA is developing a pipeline of products based on its unique
- Tafatifi — Tafatifi is an online music platform that provides information regarding music events in Egypt. It is also a music based social media.
- Fincart — Fincart is a leading shipping platform in Egypt, connecting your business with top courier services, automating operations, and helping you scale your eCommerce logistics.
At Connecticut Innovations, we see venture capital the way you see your business. Like no one else. We invest in innovative biotech, IT, and other industries.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Seed, Series A
- Geography: United States, Israel, Canada
Investor stats
- Total investments: 267
- Round size: Seed $300k–$6M; Series A $2.4M–$25M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely still investing — raised $50M in 2023
Portfolio highlights
- eBrevia — Analyze contracts at scale, extract key data, and identify risk with eBrevia. Draft and redline agreements in Microsoft Word with DraftPro.
- Mobile Sense — The traditional diagnostic market is being transformed by advances in high performance wearables. This seismic shift led by consumer products which are uncovering new patients who previously went undetected, but still require a detailed diagnosis. Mobile Sense™ is building foundational technology that enables this transformation throughoff-the-chest wearables for long term management of cardiac arrhythmias. Developed over 7 years with $4.2M in grant funding and $1.3M in seed funding, Mobile Sense™ has a platform for differentiated wearables. Our embedded algorithms coupled with non-adhesive, wireless & waterproof sensors provides high fidelity continuous ECG and PPG recordings. The automatic monitoring provides 24/7, 365 days/yr continuous detection and classification of dangerous heart arrhythmias.
- LegiTime Technologies — LegiTime Technologies, Inc. provides LegiText, a subscription-based SMS solution that offers message authentication, categorization, and archiving based on demonstration of legitimacy technology. It also provides LegiTrac that locates and tracks devices, as well as back up and stores data in a central location; and LegiAlert that offers messagebroadcasts and alerts, creates groups and contact lists, and integrates contact information with existing back office data systems. The company serves enterprises and educational institutions, as well as consumer, finance and banking, and healthcare industries. LegiTime Technologies, Inc. was founded in 2005 and is based in Farmington, Connecticut.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!We are an early stage venture capital firm dedicated to partnering with inspiring entrepreneurs to build breakthrough companies
Show more...Investment focus
- Industry: Software, Machine Learning, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 41
- Round size: Seed $1M–$2.5M; Series A $2.1M–$14M; Series B $15M–$30M
- Lead/follow: 29% lead, 71% follow
- Last fund: May invest from a new fund soon — raised $31M in 2013
Portfolio highlights
- ViewNetic — ViewNetic is an AgTech startup developing unique imaging and machine learning technologies for early, pre-propagation detection of pests and diseases in high-value crops.
- Infiniplex — Infiniplex is an Israel-based startup whose mission is to utilize routine blood testing to screen for genetic tumor biomarkers and to offer preemptive, preventive, and follow-up cancer screenings at a more accessible and affordable cost. Our goal is to identify common and rare cancer types through a standard, inexpensive blood test that could becarried out as part of routine checkups, leveraging existing laboratory equipment and know-how. We aim to include tumor genomic testing as part of people's standard blood test checkups. The company was founded in 2021 and is based in Yokne'am Illit, Israel.
- Intuition Robotics — The AI care companion robot for older adults
Robin Hood Ventures investments for startups range from $250,000 to $1 million. We syndicate with venture capitalists, institutions, and other network angels.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A
- Geography: United States, Canada, Israel
Investor stats
- Total investments: 161
- Round size: Seed $210k–$4.3M; Series A $100k–$11M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- Aseon Labs — Robotic pitstops for self driving cars. A depot in a box for charging, cleaning & inspecting AVs directly in operating zones. Backed by @ycombinator
- Cooler Heads — Cooler Heads develops cold caps designed for chemotherapy patients.
- Surface Design Solutions — Surface Design Solutions uses physics-informed AI to help manufacturers reduce scrap, improve yield, and diagnose costly surface performance issues.
XTX Ventures is the venture capital arm of XTX Markets. XTX Markets is a leading, innovation-driven algorithmic trading firm.XTX Ventures focuses on early stage startups (Seed to Series A) applying machine learning and leverages XTX Markets’ deep expertise in ML and financial technology to help grow and enhance those businesses. We are geographyand industry agnostic.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Machine Learning
- Stage:Series A, Seed
- Geography: United Kingdom, United States, Israel
Investor stats
- Total investments: 96
- Round size: Seed $2M–$7.6M; Series A $6M–$60M
- Lead/follow: 21% lead, 79% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- Jenesys AI — Meet Jack, your AI-powered bookkeeping agent, automates line-item extraction, GL coding, and bank reconciliation with real-time insights.
- Qureight — Pioneering data curation to solve complex diseases
- Proxima Fusion — We are a European fusion energy startup pursuing the clearest path to grid deployment.
TAL Ventures (TAL) is an Israel based Venture Capital group with deep ties to the Israel high-tech ecosystem.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Series A, Pre-Seed
- Geography: Israel, United States, Cyprus
Investor stats
- Total investments: 59
- Round size: Seed $3M–$12M; Pre-Seed $2.1M–$4M; Series A $5M–$25M
- Lead/follow: 24% lead, 76% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- TULU — TULU is a smart platform and amenity services provider to over 10,000 people in 50 buildings across the United States, Europe and Israel. Founded in 2019, TULU provides urban tenants with on-demand access to hundreds of brand name appliances, grocery staples, micro-mobility and entertainment devices, and more. TULU’s IoT-based modular units arecustomized to provide the most necessary and useful items, while leveraging advanced machine learning tools to analyze behavioral patterns, optimize usage, refine inventory, and create a personalized experience for our users. The outcome is a new way of living, encouraging more responsible consumption, reducing the cost of living in the city, and consistent with the trend to smaller and smaller living spaces.
- Yuki — Reduce warehouse waste, prevent budget spikes, and keep queries fast across Snowflake and BigQuery. Yuki keeps AI workloads under control with budgets and priorities built in, optimizing in real time with zero engineer effort.
- Majestic Labs ai — Majestic Labs ai builds power-efficient AI servers for the largest and most advanced AI workloads.
Insight Partners is a global software investor partnering with high-growth technology, software, and Internet startup and ScaleUp companies.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Series B, Series A, Series C
- Geography: United States, Israel, Germany
Investor stats
- Total investments: 1212
- Round size: Series A $12M–$70M; Series B $20M–$115M; Series C $27M–$150M
- Lead/follow: 66% lead, 34% follow
- Last fund: May invest from a new fund soon — raised $3.3B in 2015
Portfolio highlights
- Trustible AI — Document, manage, and report on your AI Governance strategy to build trust and reduce risk. https://www.trustible.ai/
- Pluralsight — Pluralsight is the technology workforce development company that helps teams know more and work better together with stronger skills, improved processes and informed leaders.
- commercetools — We are the world's leading commerce platform built on modern commerce principles. Start now for free.
A15 is an entrepreneurial company that invests in digital products and technology brands. They aspire to empower the human race to overcome its limits and expand its capabilities by creating real products for real people. They help them scale by providing them with investment, the support of our ecosystem, and act as their launchpad for expansion.It was founded in 1996 and is headquartered in Cairo, Egypt.
Show more...Investment focus
- Industry: E-Commerce, FinTech, Software
- Stage:Seed, Pre-Seed
- Geography: Egypt, United States, United Kingdom
Investor stats
- Total investments: 60
- Round size: Seed $100k–$8M; Pre-Seed $50k–$1.4M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- iVoiceUp — iVoiceUp is the first whistleblowing platform in MENA for anonymous reporting, case management, and compliance analytics. Detect fraud, protect reporters, and build defensible compliance.
- Byit — Byit is a technology platform developed to empower independent real estate brokers and freelancers.
- KNOT Technologies — AI-powered solutions designed to untangle event ticketing inefficiencies
Good Company Fund is investing in early-stage companies that leverage deep technologies to solve the world’s biggest problems. The firm is constantly seeking bold entrepreneurs who are building frontier technology solutions. Good Company Fund is generally looking to invest in innovative, hyper scalable, software solutions. It is especially excitedabout: Future of Energy, Future of Work and Education, Future of Work, Circular Economy, Precision Farming, and Digital Health. However, it is constantly learning and looking for additional opportunities in other verticals and aiming to invest in the "Operating System of the New, Sustainable World".Good Company's studio brings together multinational corporations, entrepreneurs and capital, in order to solve the world’s biggest problems. Good Company Studio is a home for entrepreneurs who want to create businesses with a purpose. The Studio is a pre-seed platform that provides entrepreneurs with capital, network, go-to-market, mentoring, and support.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Recruiting
- Stage:Seed, Pre-Seed, Series A
- Geography: Israel, United States
Investor stats
- Total investments: 20
- Round size: Seed $700k–$22M; Pre-Seed $400k–$4.8M; Series A $5M–$17M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Jotit — Jotit is a cutting-edge educational technology startup that uses handwriting tools to help kids, instructors, and parents stay organized.
- TULU — TULU is a smart platform and amenity services provider to over 10,000 people in 50 buildings across the United States, Europe and Israel. Founded in 2019, TULU provides urban tenants with on-demand access to hundreds of brand name appliances, grocery staples, micro-mobility and entertainment devices, and more. TULU’s IoT-based modular units arecustomized to provide the most necessary and useful items, while leveraging advanced machine learning tools to analyze behavioral patterns, optimize usage, refine inventory, and create a personalized experience for our users. The outcome is a new way of living, encouraging more responsible consumption, reducing the cost of living in the city, and consistent with the trend to smaller and smaller living spaces.
- Algocell — Optimize precision fermentation and cell culture bioprocesses using Digital Twin, AI and Hybrid Models. Create your first model now!
OTV focuses on round A+ startups that aim to make a significant impact on people's lives. Our focus is on entrepreneurs with innovative ideas who are advancing the global state of well-being. Come join the digital health revolution, and be a part of transforming the healthcare industry.
Show more...Investment focus
- Industry: Health Care, Medical, Artificial Intelligence
- Stage:Series A, Series B, Seed
- Geography: United States, Israel, Ghana
Investor stats
- Total investments: 21
- Lead/follow: no public data
Portfolio highlights
- Scopio — Buy & sell images on the largest Solana Photography NFT Marketplace. Find high-quality stock images & hire artists from around the world.
- Scopio Labs — Scopio Labs is a provider of Full Field Morphology dedicated to unlocking the potential of imaging and AI in hematology. Uncovering actionable insights from vast amounts of data readily available in the average blood sample and bone marrow aspirate, Scopio's solutions will aim to showcase thousands of cells at scale in high resolution, toenable new hematology diagnostic methods.
- Stake — Renters earn Cash back for rent. Building operators outperform the market. That's the Stake win-win. Find out how we're building the financial tools for the next generation of rentals.
Impact investing in Israeli technology. ZORA is an impact investing fund investing in early-stage Israeli companies solving global challenges in health, education, economic inclusion and the environment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Internet
- Stage:Seed, Series A, Convertible Note
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 14
- Round size: Seed $1M–$7M; Series A $4M–$8.1M
- Lead/follow: 7% lead, 93% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Newmoo — Newmoo makes plant-based cheeses and dairy alternatives.
- WeedOut — WeedOut: Exploiting Sterility against Resistant Weeds
- Forsea Foods — Forsea Foods develops cell-cultured seafood through the use of patented organoid technology which allows them to bypass the scaffolding stage of cultivated meat production.
Accelmed is a venture capital firm that funds private and public medical device companies with significant market potential and proven clinical data.Concentrating on medical device companies that have already reached the revenue stage enables the firm to assist companies in benefiting from its managerial capabilities and financial resources.Together with the management teams of their portfolio companies, the Accelmed can steer the way from the clinical-stage to a profitable business with a clear commercial plan, thereby accelerating the path to a successful exit.In 2009, Mori Arkin and Uri Geiger, the co-founders of Accelmed, established the firm in Herzliya, Tel Aviv.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series D, Series A
- Geography: Israel, United States
Investor stats
- Total investments: 37
- Round size: Series A $695k–$24M; Series D $13M–$96M
- Lead/follow: 46% lead, 54% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Corvia Medical — Corvia Medical is a medical device company, focuses on developing structural heart devices for the treatment of heart failure. The company develops InterAtrial Shunt Device (IASD), a transcatheter device designed to treat diastolic heart failure (DHF), also known as heart failure with preserved ejection fraction (HFpEF). It was founded in 2009and headquartered in Andover, Massachusetts.
- UltraClear —
- GT Medical Technologies — GT Medical Technologies, Inc. (GT), an Arizona-based medical device company, is focused on improving the lives of patients with brain tumors. GT has developed an innovative approach to treatment by combining a conformable collagen matrix with brachytherapy (radiation) seeds. The company's first product, GammaTile™ is protected by 10 US and 2Canadian issued patents, and 1 EPO patent. The product has the promise to revolutionize treatment for 176,000 patients/year in the US alone. To date, we have treated 120 patients with recurrent brain tumors in a clinical trial at Barrow Neurological Institute (BNI) and observed significant clinical improvement.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Binder & Partners Ventures is the investments' capital arm of Binder & Partners multi-family office. The ambition of BPV is to connect our investors with the most promising startup companies.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Pre-Seed, Series A
- Geography: Israel, France, United States
Investor stats
- Total investments: 14
- Lead/follow: no public data
Portfolio highlights
- Rookout — Code doesn’t always behave as you expect it to and your team is wasting too much time to understand why. Rookout provides secure, fast, and simple data access, no matter what architecture or where the code is running. By providing the developer with instant, laser-focused data, developer teams can understand their code and see an increase inproductivity, velocity, and efficiency.
- Lumen — Lumen is a device and app that measures your metabolism in a single breath and provides daily personalized nutrition based on your metabolic data. Through the device and app, you can achieve your fitness goals whether they be weight loss, performance optimization, or simply improving your metabolic health.As a company, we are a team ofscientists, researchers, engineers, and designers, aimed at improving the way people understand their metabolism. We believe that a healthy metabolism is a key to better health and that everyone can attain it with a little help from Lumen.At Lumen, we are all about teamwork, friendship, and family. Curious about joining? We are always looking for creative people who share our passion for health and fitness to join our team.
- Blink Technologies — Blink Technologies is developing a robust, non-intrusive passive, eye-tracking technology without the need for special dedicated hardware. Their non-invasive, AI-based Software Solution can be deployed with any Camera technology on the market today. The proprietary solution integrates with any OS and can run locally (edge-based) or remotely(cloud-based).Blink Technologies was founded in 2018 and is based in Palo Alto, California, United States.
Yozma earned worldwide recognition as the founder of Israel's VC industry.
Show more...Investment focus
- Industry: Health Care, Medical, Software
- Stage:Series B, Seed
- Geography: Israel, United States, Australia
Investor stats
- Total investments: 24
- Round size: Seed $4M–$4.5M; Series B $2.5M–$59M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- BiSiChem — Invent targeted small molecule drugs that are either first-in-class or second-generation
- Illumigyn — Technology that we developed, creating high-resolution digital images with superior magnification that can substantially improve diagnostic accuracy.
- Meat.The End — MTE revolutionizes food production to create desired textures and provides a solution for food companies, by developing novel ingredients and technological solutions that enhance the texture properties of alternative protein products.
DAI works on the frontlines of global development transforming ideas into action—action into impact.
Show more...Investment focus
- Industry: Health Care, Medical, Software
- Stage:Seed
- Geography: United States, Egypt
Investor stats
- Total investments: 4
- Lead/follow: no public data
Portfolio highlights
- Rology — AI-assisted On-demand Teleradiology Platform
- THINKMD — THINKMD develops next-generation clinical assessment and data analytics platforms that transform point-of-care medicine by putting medically validated clinical assessment capability into the hands of non-healthcare professionals. This technology allows for the decentralization of healthcare delivery into communities and homes by pairing clinicalknowledge and Bayesian/pattern recognition algorithms with simple to use mobile technology. Its goal is to reinvent the healthcare delivery paradigm, reduce costs, and improve outcomes by improving healthcare access and care-seeking behavior while building a public health knowledge database.
- ClickMedix — Note: you must have a demo account to use the apps Improved Health Professionals Saved
Flerie is an active long-term life science investor, focusing on biotech and pharmaceutical investments globally.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B
- Geography: Sweden, Israel, Iceland
Investor stats
- Total investments: 13
- Lead/follow: no public data
Portfolio highlights
- AnaCardio — AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility and aims to improve clinical outcomes in heart failure.
- XNK Therapeutics — XNK Therapeutics, founded in 2012, is one of the pioneering companies within the landscape of cell therapy.
- Vitara Biomedical — Vitara Biomedical has developed a therapeutic platform to support premature infants. Vitara Biomedical's platform was inspired by natural physiological processes to transform neonatal care.
Elron Ventures is an early-stage investor committed to turning promising ideas into global industry leaders, with a proven track record of investments and successful M&As worldwide. Elron invests in cyber security and B2B software. Since its establishment in 1962, Elron stands on the forefront of Israeli innovation both as a founder and earlyinvestor in companies across various industries such as Elbit, Medingo, Given Imaging, Cloudyn, Cyber Secdo, and Alcide.
Show more...Investment focus
- Industry: Information Technology, Software, Health Care
- Stage:Seed, Series A
- Geography: Israel, United States, China
Investor stats
- Total investments: 62
- Lead/follow: no public data
Portfolio highlights
- Cybersixgill — Cybersixgill is the leader in cyber threat intelligence enablement and enrichment. Their fully automated threat intelligence solutions help organizations fight cyber crime, detect phishing, data leaks, fraud and vulnerabilities as well as amplify incident response – in real-time. The Cybersixgill Investigative Portal empowers security teams withcontextual and actionable insights as well as the ability to conduct real-time investigations. Rich data feeds such as Darkfeed™ and DVE Score™ harness Cybersixgill’s unmatched intelligence collection capabilities and deliver real-time intel into organizations' existing security systems. Most recently, Cybersixgill introduced agility to threat intel with their CI/CP methodology (Continuous Investigation/Continuous Protection). Current customers include enterprises, financial services, MSSPs, governments and law enforcement entities.
- CartiHeal — Target improved outcomes in the treatment of knee cartilage and osteochondral defects with a porous, biocompatible and biodegradable off-the-shelf implant.
- Brainsgate — Established in 2000, BrainsGate is a medical device company committed to developing innovative therapies for patients suffering from Central Nervous System (CNS) diseases.BrainsGate's platform...
HealthpointCapital, LLC is a values-based, research-driven private equity firm that is differentiated by its focus on the musculoskeletal industry. HealthpointCapital has over $800 million of assets under management, including co-investments, resulting in 24 corporate acquisitions for HealthpointCapital's seven platform businesses. The sevenplatform companies, Alphatec Spine, Inc., BioHorizons Implant Systems, Inc., Blue Belt Technologies, Inc., China Rehabilitation Ltd., MicroDental, Inc., Nexa Orthopedics, Inc. and OrthoAccel Technologies, Inc., represent outstanding platforms in some of the key high-growth segments of the orthopedic industry: Robotics, Spine, Dental, Extremities and Emerging Markets.
Show more...Investment focus
- Industry: Medical, Biotechnology, Manufacturing
- Stage:Series B, Series C
- Geography: Israel, United States
Investor stats
- Total investments: 7
- Round size: Series B $5M–$13M; Series C $12M–$15M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- OrthoSpace — OrthoSpace develops and commercializes simple-to-implant, biodegradable balloon systems for the orthopaedic market. The company aims to create effective solutions for orthopaedics that reduce pain and increase patients’ range of motion while preserving patient bone and joint structures.The company’s first product has the CE mark and iscurrently marketed in Europe. InSpace™ is indicated for patients who suffer from rotator cuff injury, reducing shoulder pain and improving range of motion.
- OrthoAccel Technologies — Straighten Your Smile Faster With AcceleDent SoftPulse Technology. Simple To Use, Allowing Braces To Feel More Comfortable With Only 20 Minutes Daily Use!
Smith & Nephew PLC designs, manufactures and markets orthopedic devices, sports medicine and ENT technologies, and wound-care solutions. Slightly more than 40% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is a sports medicine and ENT. The remaining 27% of revenue is from the advanced wound therapysegment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Show more...Investment focus
- Industry: Medical Device, Medical, Health Care
- Stage:Series B, Series C
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 5
- Round size: Series B $2.7M–$30M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- OrthoSpace — OrthoSpace develops and commercializes simple-to-implant, biodegradable balloon systems for the orthopaedic market. The company aims to create effective solutions for orthopaedics that reduce pain and increase patients’ range of motion while preserving patient bone and joint structures.The company’s first product has the CE mark and iscurrently marketed in Europe. InSpace™ is indicated for patients who suffer from rotator cuff injury, reducing shoulder pain and improving range of motion.
- Trice Medical — Perform a full diagnostic arthroscopy on an HD tablet thanks to the mi-eye 2. Get mi-eye 2 for your doctor's office today.
- Miach Orthopaedics — Miach Orthopaedics is a medical device company that develops bio-engineered surgical implants to facilitate new tissue growth. The company's product is the Bridge-Enhanced ACL Repair technology as a viable alternative to conventional ACL reconstruction for patients who have withstand an anterior cruciate ligament injury.Miach Orthopaedicswas founded on 2016 and is headquartered in Westborough, Massachusetts.
fresh.fund is an Israeli pre-seed venture capital fund investing in early-stage startups across segments and verticals.We're built to partner with early-stage founders from day one, often as the company's first institutional investors. Our model is refreshingly simple: up to $300,000 in pre-seed funding within <4 weeks and follow-oncapital as necessary.Check out our portfolio here >> https://www.fresh.fund/portfolio. It's never too early to have a conversation about your startup.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: Israel, United States, Norway
Investor stats
- Total investments: 43
- Round size: Seed $2.2M–$12M; Pre-Seed $300k–$6M; Series A $11M–$21M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- Kimba — Heal your mind, improve your sleep, and boost your health with Kimba's AI scent technology. Join Kimba and start sleeping better today!
- Wisio — Wisio lets social media creators and experts answer questions and requests from followers via paid interactions. The company’s platform empowers followers to gain exclusive access via personalized videos to their favorite creators. Wisio's flexible and easy-to-use platform is packed with features to help creators build deeper communitieswhile monetizing the creator - follower relationship. Thousands of them are already using it to help build their online reputation and business.Wisio's vision is to make everyone reachable.
- Shifters AI — Shifters AI is a software company that develops artificial intelligence and robotic solutions.
Mangrove Capital Partners is a contrarian investment firm helping innovative entrepreneurs start and grow.
Show more...Investment focus
- Industry: Software, E-Commerce, Information Technology
- Stage:Series A, Seed, Series B
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 142
- Lead/follow: no public data
Portfolio highlights
- Exoticca — Exoticca develops an online platform intended to facilitate travel booking. The company's platform offers holiday packages which includes flights, accommodation, meals, guides and private transports, for exotic locations all around the world, enabling travelers to book travel packages online at competitive prices.
- K Health — We pair clinicians with advanced AI to provide data-driven, personalized care around the clock. Chat with your medical team today.
- Brain.space — Brain.space is a brain-mapping data company that is on a mission to provide researchers, medical practitioners and software developers the underlying foundation to interpret, analyze, and build brain activity products and services. The end-to-end technology stack aims to power products, services, and apps that access and interpret brain activitydata.
Angular Ventures is a specialist venture capital firm committed to founders redefining global markets.
Show more...Investment focus
- Industry: Software, SaaS, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 74
- Round size: Seed $2.3M–$8M; Pre-Seed $1.2M–$3.1M; Series A $7M–$45M
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- Medida AI — Medida is an AI virtual measuring system that provides accurate digitized measurements for home renovation companies.
- Reco — SaaS Security Leverage Reco's context analysis to streamline SaaS security, minimize data and identity risk, and automate remediation
- groundcover — Instantly pinpoint bleeding issues in production & troubleshoot quickly with groundcover. All with zero code changes.
FAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical VC Funds in Middle East investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 48,091 VC funds investing in Middle East Medical startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!